Key clinical point: Cancer patients with nosocomial COVID-19 had more than double the mortality rate of cancer patients with community-acquired COVID-19.
Major finding: The all-cause mortality rate was 47% in patients with nosocomial COVID-19 and 23% in those with community-acquired COVID-19.
Study details: An observational study of 253 patients with COVID-19 and cancer.
Disclosures: Dr. Elkrief reported grant support from AstraZeneca.
Elkrief A et al. AACR: COVID-19 and Cancer, Abstract S12-01.